Aptose Biosciences, Inc. - stock earnings
APTO Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -11.4 million USD | ? USD |
2023Q2 | -14.1 million USD | ? USD |
2023Q1 | -13.1 million USD | ? USD |
2022Q4 | -10.4 million USD | ? USD |
2022Q3 | -9.5 million USD | ? USD |
2022Q2 | -10.5 million USD | ? USD |
2022Q1 | -11.5 million USD | ? USD |
2021Q4 | -24.3 million USD | ? USD |
2021Q3 | -11.3 million USD | ? USD |
2021Q2 | -13.5 million USD | ? USD |
2021Q1 | -16.2 million USD | ? USD |
2020Q4 | -14.7 million USD | ? USD |
2020Q3 | -13.2 million USD | ? USD |
2020Q2 | -15.8 million USD | ? USD |
2020Q1 | -11.5 million USD | ? USD |
2019Q4 | -7.7 million USD | ? USD |
2019Q3 | -6.8 million USD | ? USD |
2019Q2 | -6.2 million USD | ? USD |
2019Q1 | -5.5 million USD | ? USD |
2018Q4 | -6.3 million USD | ? USD |
2018Q3 | -5.5 million USD | ? USD |
2018Q2 | -10.3 million USD | ? USD |
2018Q1 | -6.8 million USD | ? USD |
2017Q4 | -2.9 million USD | ? USD |
2017Q3 | -2.7 million USD | ? USD |
2017Q2 | -2.5 million USD | ? USD |
2017Q1 | -3.3 million USD | ? USD |
2016Q4 | -2.9 million USD | ? USD |
2016Q3 | -3.1 million USD | ? USD |
2016Q2 | -4.3 million USD | ? USD |
2016Q1 | -3.9 million USD | ? USD |
2015Q4 | -3.2 million USD | ? USD |
2015Q3 | -2.4 million USD | ? USD |
2015Q2 | -2.7 million USD | ? USD |
2015Q1 | -2.8 million USD | ? USD |
2014Q4 | -3.1 million USD | ? USD |
2014Q2 | 9.9 million USD | ? USD |
2014Q1 | -3.9 million USD | ? USD |
2013Q4 | -2.2 million USD | ? USD |
2013Q3 | -2.6 million USD | ? USD |
2013Q2 | -1.0 million USD | ? USD |
2013Q1 | -1.2 million USD | ? USD |
2012Q4 | -1.3 million USD | ? USD |
2012Q3 | -1.6 million USD | ? USD |
2012Q2 | -1.3 million USD | ? USD |
2012Q1 | -855626 USD | ? USD |
2011Q4 | -1.0 million USD | ? USD |
2011Q3 | -1.4 million USD | ? USD |
2011Q2 | -1.1 million USD | ? USD |
2011Q1 | -1.1 million USD | ? USD |
2010Q4 | -1.6 million USD | ? USD |
2010Q3 | -1.2 million USD | ? USD |
2010Q2 | -1.1 million USD | ? USD |
2010Q1 | -1.8 million USD | -474 USD |
2009Q4 | -1.3 million USD | 2854 USD |
2009Q3 | -1.2 million USD | 74690 USD |
2009Q2 | 8.9 million USD | 44738 USD |
2009Q1 | -2.6 million USD | 85313 USD |
2008Q4 | -1.9 million USD | 50411 USD |
2008Q3 | -1.8 million USD | 30916 USD |
2008Q2 | -2.1 million USD | 2811 USD |
2008Q1 | 2.8 million USD | 11925 USD |
2007Q4 | -3.9 million USD | 3009 USD |
2007Q3 | -2.8 million USD | 1000 USD |
2007Q2 | 3.8 million USD | 24968 USD |
2007Q1 | -2.2 million USD | 43031 USD |
2006Q4 | -1.8 million USD | 31995 USD |
2006Q3 | -2.7 million USD | 20007 USD |
2006Q2 | -2.5 million USD | 5996 USD |
2006Q1 | -3.1 million USD | 13018 USD |
2005Q4 | -3.6 million USD | 3993 USD |
2005Q3 | -4.4 million USD | 4985 USD |
2005Q2 | -4.8 million USD | 999 USD |
2005Q1 | -3.4 million USD | 1 USD |
2004Q4 | -4.8 million USD | 1998 USD |
2004Q3 | -5.0 million USD | 1000 USD |
2004Q2 | -4.8 million USD | 1998 USD |
2004Q1 | -5.5 million USD | -7248 USD |
2003Q4 | -6.1 million USD | 1002 USD |
2003Q3 | -4.6 million USD | 443124 USD |
2003Q2 | -5.9 million USD | 21031 USD |
2003Q1 | -4.1 million USD | 29806 USD |
2002Q4 | -2.6 million USD | 18016 USD |
2002Q3 | -2.5 million USD | ? USD |
2002Q2 | -2.6 million USD | ? USD |
2002Q1 | -2.7 million USD | ? USD |
2001Q4 | -1.9 million USD | ? USD |
2001Q3 | -2.3 million USD | ? USD |
2001Q2 | -2.0 million USD | 1000 USD |
2001Q1 | -4.0 million USD | 349 USD |
2000Q4 | -1.8 million USD | 650 USD |
2000Q3 | -2.5 million USD | 651 USD |
2000Q2 | -1.7 million USD | 678 USD |
2000Q1 | -3.4 million USD | -68247 USD |
1999Q4 | -1.2 million USD | 68915 USD |
1999Q3 | -679098 USD | 67909 USD |
1999Q2 | -468368 USD | 66909 USD |
1999Q1 | -932119 USD | 1529 USD |
1998Q4 | -596619 USD | 66291 USD |
1998Q3 | -651041 USD | 65104 USD |
1998Q2 | -949126 USD | 63275 USD |
1998Q1 | -345860 USD | -1611 USD |
1997Q4 | -1.1 million USD | 70264 USD |
1997Q3 | -1.1 million USD | 70274 USD |
1997Q2 | -719942 USD | 71994 USD |
APTO Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -49.3 million USD | ? USD |
2022 | -41.1 million USD | ? USD |
2021 | -65.3 million USD | ? USD |
2020 | -54.7 million USD | ? USD |
2019 | -25.7 million USD | ? USD |
2018 | -28.9 million USD | ? USD |
2017 | -11.7 million USD | ? USD |
2016 | -13.9 million USD | ? USD |
2015 | -10.5 million USD | ? USD |
2014 | -9.7 million USD | ? USD |
2013 | -5.4 million USD | ? USD |
2012 | -4.5 million USD | ? USD |
2011 | -5.2 million USD | ? USD |
2010 | 5.1 million USD | 124156 USD |
2009 | -8.1 million USD | 168807 USD |
2008 | -6.4 million USD | 43023 USD |
2007 | -9.0 million USD | 100023 USD |
2006 | -16.3 million USD | 24000 USD |
2005 | -16.3 million USD | 24000 USD |
2004 | -17.6 million USD | 4998 USD |
2003 | -22.2 million USD | 446694 USD |
2002 | -8.8 million USD | 47822 USD |
2001 | -8.8 million USD | ? USD |
2000 | -9.9 million USD | 1000 USD |
1999 | -5.7 million USD | 667 USD |
1998 | -3.1 million USD | 67820 USD |
1997 | -3.2 million USD | 68653 USD |
1996 | -3.5 million USD | 72558 USD |
APTO
Price: $1.21
52 week price:
Earnings Per Share: -7.72 USD
P/E Ratio: -0.27
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 268562
Ebitda: -2.7 millionMarket Capitalization: 22.4 million